A 32-year-old G2P1 woman at 16 weeks’ gestation presents to her obstetrician complaining of fatigue, anxiety, and palpitations. She says she has been

Subject
Obstetrics and Gynaecology
System
Endocrine, Diabetes & Metabolism

Kathryn

Member
Jul 29, 2020
670
1
18
Singapore
Country flag
#april2020mccqe1

A 32-year-old G2P1 woman at 16 weeks’ gestation presents to her obstetrician complaining of fatigue, anxiety, and palpitations. She says she has been feeling warm, even in her air-conditioned home, and has been having three or four loose stools per day, as compared to one or two prior to her pregnancy. She has a temperature of 37.1°C (98.9°F), heart rate of 105/min, and blood pressure of 128/76 mm Hg. Neck examination reveals mild diffuse enlargement of the thyroid gland with no lymphadenopathy. Relevant laboratory findings include a total triiodothyronine level of 400 ng/dL, free thyroxine of 6.8 ng/dL, and thyroid-stimulating hormone of 0.01 μU/mL (normal: 0.4–4 μU/L). Results of a thyroid- stimulating hormone-receptor antibody test are positive. Which of the following is the most appropriate therapy for this patient?
(A) High-dose iodine therapy
(B) Methimazole
(C) Propylthiouracil
(D) Radioiodine ablation
(E) Surgical resection
 
Last edited by a moderator: